Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Anaemia and Iron Homeostasis in a Cohort of HIV-Infected Patients: A Cross-Sectional Study in Ghana.

Identifieur interne : 000262 ( PubMed/Corpus ); précédent : 000261; suivant : 000263

Anaemia and Iron Homeostasis in a Cohort of HIV-Infected Patients: A Cross-Sectional Study in Ghana.

Auteurs : Christian Obirikorang ; Razak Gyesi Issahaku ; Derick Nii Mensah Osakunor ; James Osei-Yeboah

Source :

RBID : pubmed:27092270

Abstract

Aim. We determined the prevalence of anaemia and evaluated markers of iron homeostasis in a cohort of HIV patients. Methods. A comparative cross-sectional study on 319 participants was carried out at the Tamale Teaching Hospital from July 2013 to December 2013, 219 patients on HAART (designated On-HAART) and 100 HAART-naive patients. Data gathered include sociodemography, clinical history, and selected laboratory assays. Results. Prevalence of anaemia was 23.8%. On-HAART participants had higher CD4/CD3 lymphocyte counts, Hb, HCT/PCV, MCV, MCH, iron, ferritin, and TSAT (P < 0.05). Hb, iron, ferritin, and TSAT decreased from grade 1 to grade 3 anaemia and CD4/CD3 lymphocyte count was lowest in grade 3 anaemia (P < 0.05). Iron (P = 0.0072) decreased with disease severity whilst transferrin (P = 0.0143) and TIBC (P = 0.0143) increased with disease severity. Seventy-six (23.8%) participants fulfilled the criteria for anaemia, 86 (26.9%) for iron deficiency, 41 (12.8%) for iron deficiency anaemia, and 17 (5.3%) for iron overload. The frequency of anaemia was higher amongst participants not on HAART (OR 2.6 for grade 1 anaemia; OR 3.0 for grade 3 anaemia). Conclusion. In this study population, HIV-associated anaemia is common and is related to HAART status and disease progression. HIV itself is the most important cause of anaemia and treatment of HIV should be a priority compared to iron supplementation.

DOI: 10.1155/2016/1623094
PubMed: 27092270

Links to Exploration step

pubmed:27092270

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Anaemia and Iron Homeostasis in a Cohort of HIV-Infected Patients: A Cross-Sectional Study in Ghana.</title>
<author>
<name sortKey="Obirikorang, Christian" sort="Obirikorang, Christian" uniqKey="Obirikorang C" first="Christian" last="Obirikorang">Christian Obirikorang</name>
<affiliation>
<nlm:affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Issahaku, Razak Gyesi" sort="Issahaku, Razak Gyesi" uniqKey="Issahaku R" first="Razak Gyesi" last="Issahaku">Razak Gyesi Issahaku</name>
<affiliation>
<nlm:affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Medical Laboratory Department, Tamale Teaching Hospital, Tamale, Ghana.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Osakunor, Derick Nii Mensah" sort="Osakunor, Derick Nii Mensah" uniqKey="Osakunor D" first="Derick Nii Mensah" last="Osakunor">Derick Nii Mensah Osakunor</name>
<affiliation>
<nlm:affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Osei Yeboah, James" sort="Osei Yeboah, James" uniqKey="Osei Yeboah J" first="James" last="Osei-Yeboah">James Osei-Yeboah</name>
<affiliation>
<nlm:affiliation>Department of Medical Laboratory Sciences, University of Health and Allied Sciences, Ho, Ghana.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27092270</idno>
<idno type="pmid">27092270</idno>
<idno type="doi">10.1155/2016/1623094</idno>
<idno type="wicri:Area/PubMed/Corpus">000262</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000262</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Anaemia and Iron Homeostasis in a Cohort of HIV-Infected Patients: A Cross-Sectional Study in Ghana.</title>
<author>
<name sortKey="Obirikorang, Christian" sort="Obirikorang, Christian" uniqKey="Obirikorang C" first="Christian" last="Obirikorang">Christian Obirikorang</name>
<affiliation>
<nlm:affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Issahaku, Razak Gyesi" sort="Issahaku, Razak Gyesi" uniqKey="Issahaku R" first="Razak Gyesi" last="Issahaku">Razak Gyesi Issahaku</name>
<affiliation>
<nlm:affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Medical Laboratory Department, Tamale Teaching Hospital, Tamale, Ghana.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Osakunor, Derick Nii Mensah" sort="Osakunor, Derick Nii Mensah" uniqKey="Osakunor D" first="Derick Nii Mensah" last="Osakunor">Derick Nii Mensah Osakunor</name>
<affiliation>
<nlm:affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Osei Yeboah, James" sort="Osei Yeboah, James" uniqKey="Osei Yeboah J" first="James" last="Osei-Yeboah">James Osei-Yeboah</name>
<affiliation>
<nlm:affiliation>Department of Medical Laboratory Sciences, University of Health and Allied Sciences, Ho, Ghana.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">AIDS research and treatment</title>
<idno type="ISSN">2090-1240</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Aim. We determined the prevalence of anaemia and evaluated markers of iron homeostasis in a cohort of HIV patients. Methods. A comparative cross-sectional study on 319 participants was carried out at the Tamale Teaching Hospital from July 2013 to December 2013, 219 patients on HAART (designated On-HAART) and 100 HAART-naive patients. Data gathered include sociodemography, clinical history, and selected laboratory assays. Results. Prevalence of anaemia was 23.8%. On-HAART participants had higher CD4/CD3 lymphocyte counts, Hb, HCT/PCV, MCV, MCH, iron, ferritin, and TSAT (P < 0.05). Hb, iron, ferritin, and TSAT decreased from grade 1 to grade 3 anaemia and CD4/CD3 lymphocyte count was lowest in grade 3 anaemia (P < 0.05). Iron (P = 0.0072) decreased with disease severity whilst transferrin (P = 0.0143) and TIBC (P = 0.0143) increased with disease severity. Seventy-six (23.8%) participants fulfilled the criteria for anaemia, 86 (26.9%) for iron deficiency, 41 (12.8%) for iron deficiency anaemia, and 17 (5.3%) for iron overload. The frequency of anaemia was higher amongst participants not on HAART (OR 2.6 for grade 1 anaemia; OR 3.0 for grade 3 anaemia). Conclusion. In this study population, HIV-associated anaemia is common and is related to HAART status and disease progression. HIV itself is the most important cause of anaemia and treatment of HIV should be a priority compared to iron supplementation.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">27092270</PMID>
<DateCreated>
<Year>2016</Year>
<Month>04</Month>
<Day>19</Day>
</DateCreated>
<DateCompleted>
<Year>2016</Year>
<Month>04</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2090-1240</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>2016</Volume>
<PubDate>
<Year>2016</Year>
</PubDate>
</JournalIssue>
<Title>AIDS research and treatment</Title>
<ISOAbbreviation>AIDS Res Treat</ISOAbbreviation>
</Journal>
<ArticleTitle>Anaemia and Iron Homeostasis in a Cohort of HIV-Infected Patients: A Cross-Sectional Study in Ghana.</ArticleTitle>
<Pagination>
<MedlinePgn>1623094</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1155/2016/1623094</ELocationID>
<Abstract>
<AbstractText>Aim. We determined the prevalence of anaemia and evaluated markers of iron homeostasis in a cohort of HIV patients. Methods. A comparative cross-sectional study on 319 participants was carried out at the Tamale Teaching Hospital from July 2013 to December 2013, 219 patients on HAART (designated On-HAART) and 100 HAART-naive patients. Data gathered include sociodemography, clinical history, and selected laboratory assays. Results. Prevalence of anaemia was 23.8%. On-HAART participants had higher CD4/CD3 lymphocyte counts, Hb, HCT/PCV, MCV, MCH, iron, ferritin, and TSAT (P < 0.05). Hb, iron, ferritin, and TSAT decreased from grade 1 to grade 3 anaemia and CD4/CD3 lymphocyte count was lowest in grade 3 anaemia (P < 0.05). Iron (P = 0.0072) decreased with disease severity whilst transferrin (P = 0.0143) and TIBC (P = 0.0143) increased with disease severity. Seventy-six (23.8%) participants fulfilled the criteria for anaemia, 86 (26.9%) for iron deficiency, 41 (12.8%) for iron deficiency anaemia, and 17 (5.3%) for iron overload. The frequency of anaemia was higher amongst participants not on HAART (OR 2.6 for grade 1 anaemia; OR 3.0 for grade 3 anaemia). Conclusion. In this study population, HIV-associated anaemia is common and is related to HAART status and disease progression. HIV itself is the most important cause of anaemia and treatment of HIV should be a priority compared to iron supplementation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Obirikorang</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Issahaku</LastName>
<ForeName>Razak Gyesi</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Medical Laboratory Department, Tamale Teaching Hospital, Tamale, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Osakunor</LastName>
<ForeName>Derick Nii Mensah</ForeName>
<Initials>DN</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Osei-Yeboah</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Laboratory Sciences, University of Health and Allied Sciences, Ho, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>03</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AIDS Res Treat</MedlineTA>
<NlmUniqueID>101553816</NlmUniqueID>
<ISSNLinking>2090-1240</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 2004 May 15;38(10):1454-63</RefSource>
<PMID Version="1">15156485</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Infect Dis. 2008 Apr 22;8:52</RefSource>
<PMID Version="1">18430196</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MMWR Recomm Rep. 1997 Jan 10;46(RR-2):1-29</RefSource>
<PMID Version="1">9011774</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):219-25</RefSource>
<PMID Version="1">16186741</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Med. 2004 Apr 5;116 Suppl 7A:27S-43S</RefSource>
<PMID Version="1">15050884</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS Patient Care STDS. 2002 Aug;16(8):361-5</RefSource>
<PMID Version="1">12227986</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biomed Sci. 2009 Nov 18;16:102</RefSource>
<PMID Version="1">19922646</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):498-507</RefSource>
<PMID Version="1">18077841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):70-4</RefSource>
<PMID Version="1">19574926</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Nutr. 2002 Apr;132(4 Suppl):827S-30S</RefSource>
<PMID Version="1">11925490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):54-7</RefSource>
<PMID Version="1">11782590</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2010 Aug 7;376(9739):449-57</RefSource>
<PMID Version="1">20638120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Nutr. 2008 Mar;138(3):613-9</RefSource>
<PMID Version="1">18287375</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anemia. 2011;2011:260380</RefSource>
<PMID Version="1">21738863</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Biochem Funct. 1999 Dec;17(4):279-87</RefSource>
<PMID Version="1">10587615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>ISRN AIDS. 2013 Dec 10;2013:873939</RefSource>
<PMID Version="1">24386593</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS Rev. 2002 Jan-Mar;4(1):13-20</RefSource>
<PMID Version="1">11998779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Public Health. 2014 Mar 07;14:236</RefSource>
<PMID Version="1">24606888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Infect Dis. 2011 Aug 09;11:213</RefSource>
<PMID Version="1">21827653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2006 Aug 16;296(7):782-93</RefSource>
<PMID Version="1">16905784</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Niger J Med. 2005 Jan-Mar;14(1):33-8</RefSource>
<PMID Version="1">15832640</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 2007 Jul;77(1):44-51</RefSource>
<PMID Version="1">17620629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1245-52</RefSource>
<PMID Version="1">15385731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Tanzan J Health Res. 2009 Jan;11(1):1-4</RefSource>
<PMID Version="1">19445097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 1998 Jan 1;91(1):301-8</RefSource>
<PMID Version="1">9414298</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Investig Med. 2001 May;49(3):225-39</RefSource>
<PMID Version="1">11352180</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Clin Nutr. 2004 Apr;58(4):681-91</RefSource>
<PMID Version="1">15042138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Infect Dis. 2009 Jan 13;9:1</RefSource>
<PMID Version="1">19144106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Baillieres Clin Haematol. 1994 Dec;7(4):829-49</RefSource>
<PMID Version="1">7881156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19</RefSource>
<PMID Version="1">1361652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antivir Ther. 2008;13(8):959-67</RefSource>
<PMID Version="1">19195321</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J STD AIDS. 1998 Aug;9(8):463-70</RefSource>
<PMID Version="1">9702595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2006 May 12;20(8):1181-9</RefSource>
<PMID Version="1">16691070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 1999 May 28;13(8):943-50</RefSource>
<PMID Version="1">10371175</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MMWR Recomm Rep. 2003 Jan 31;52(RR-2):1-13</RefSource>
<PMID Version="1">12583540</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>HIV Med. 2007 Sep;8(6):388-95</RefSource>
<PMID Version="1">17661847</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC4820609</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2016</Year>
<Month>01</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>03</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>4</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>4</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>4</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27092270</ArticleId>
<ArticleId IdType="doi">10.1155/2016/1623094</ArticleId>
<ArticleId IdType="pmc">PMC4820609</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000262 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000262 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:27092270
   |texte=   Anaemia and Iron Homeostasis in a Cohort of HIV-Infected Patients: A Cross-Sectional Study in Ghana.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:27092270" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaGhanaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024